Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Free Cash Flow (2016 - 2025)

Orthopediatrics has reported Free Cash Flow over the past 10 years, most recently at $20.9 million for Q4 2025.

  • Quarterly results put Free Cash Flow at $20.9 million for Q4 2025, up 97.94% from a year ago — trailing twelve months through Dec 2025 was -$4.9 million (up 82.07% YoY), and the annual figure for FY2025 was -$4.9 million, up 82.07%.
  • Free Cash Flow for Q4 2025 was $20.9 million at Orthopediatrics, up from -$3.4 million in the prior quarter.
  • Over the last five years, Free Cash Flow for KIDS hit a ceiling of $20.9 million in Q4 2025 and a floor of -$23.9 million in Q4 2023.
  • Median Free Cash Flow over the past 5 years was -$8.4 million (2022), compared with a mean of -$6.4 million.
  • Peak annual rise in Free Cash Flow hit 144.14% in 2024, while the deepest fall reached 964.99% in 2024.
  • Orthopediatrics' Free Cash Flow stood at -$2.9 million in 2021, then grew by 1.81% to -$2.8 million in 2022, then tumbled by 747.23% to -$23.9 million in 2023, then surged by 144.14% to $10.5 million in 2024, then soared by 97.94% to $20.9 million in 2025.
  • The last three reported values for Free Cash Flow were $20.9 million (Q4 2025), -$3.4 million (Q3 2025), and -$13.9 million (Q2 2025) per Business Quant data.